---
title: "DECIPHERA PHARMACEUTICALS (UK) LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a32e3550-3d1c-5fcd-b6ad-b75e754ae428
json: https://whiteintel.dev/api/public/dossier/a32e3550-3d1c-5fcd-b6ad-b75e754ae428
identifier: oo:GB-COH-12593299
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DECIPHERA PHARMACEUTICALS (UK) LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12593299`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/a32e3550-3d1c-5fcd-b6ad-b75e754ae428  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a32e3550-3d1c-5fcd-b6ad-b75e754ae428  

## Ownership & control

### Owners / controllers

- **Deciphera Pharmaceuticals, Inc** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/87088763-1b53-4f29-ac35-6aa897c0e68b
- **Deciphera Pharmaceuticals Llc** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/e30b53f1-a6b7-4b2b-a80d-ad83a75abf06

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12593299`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2020-05-11
- **Registered office:** Suite 2, Ground Floor, Templeback,10 Temple Back, Bristol, BS1 6FL, United Kingdom
- **SIC:** 82990

### Officers

- OSTROVSKY, Maria — director · American · appointed 2024-12-16
- HELD, Jeffrey Michael — secretary · appointed 2020-05-11 · resigned 2024-09-20
- [VISTRA COSEC LIMITED](https://whiteintel.dev/entity/c0d53d7b-482f-52f7-af62-7e36b80f875b) — corporate secretary · appointed 2020-05-11 · resigned 2021-01-04
- HOERTER, Steven Larzelere — director · American · appointed 2020-05-11 · resigned 2024-12-16
- KELLY, Thomas Patrick — director · American · appointed 2020-05-11 · resigned 2024-08-08
- LARSON, Jennifer — director · American · appointed 2024-08-08 · resigned 2026-08-15

### Beneficial owners (Persons with Significant Control)

- [Deciphera Pharmaceuticals, Inc](https://whiteintel.dev/entity/87088763-1b53-4f29-ac35-6aa897c0e68b) — 50–75% shares · corporate PSC · United States — since 2020-11-23
- [Deciphera Pharmaceuticals Llc](https://whiteintel.dev/entity/e30b53f1-a6b7-4b2b-a80d-ad83a75abf06) — 75–100% shares · corporate PSC · United States — ceased 2020-11-23

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12593299
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/12593299

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **DECIPHERA PHARMACEUTICALS (UK) LIMITED** — https://whiteintel.dev/entity/a32e3550-3d1c-5fcd-b6ad-b75e754ae428 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DECIPHERA PHARMACEUTICALS (UK) LIMITED**. Human view: https://whiteintel.dev/entity/a32e3550-3d1c-5fcd-b6ad-b75e754ae428 · Structured JSON: https://whiteintel.dev/api/public/dossier/a32e3550-3d1c-5fcd-b6ad-b75e754ae428._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._